Matthew P. Young, EVP & CFO at Jazz Pharmaceuticals plc (JAZZ), sold 7,610 shares at $144.96 ($1.1M) on 2018-02-27, disclosed to the SEC on 2018-02-28.
Open-market sale of $1.1M JAZZ by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.44 | 2,253 | $332K | 29.8% |
| 2 | $143.80 | 606 | $87K | 7.8% |
| 3 | $144.96 | 1,016 | $147K | 13.2% |
| 4 | $144.96 | 1,016 | $147K | 13.2% |
| 5 | $145.83 | 600 | $87K | 7.9% |
| 6 | $145.83 | 600 |
| $87K |
| 7.9% |
| 7 | $147.30 | 300 | $44K | 4.0% |
| 8 | $145.25 | 200 | $29K | 2.6% |
| 9 | $147.56 | 119 | $18K | 1.6% |
| 10 | $149.02 | 200 | $30K | 2.7% |
| 11 | $150.00 | 700 | $105K | 9.4% |
| Total | $146.45 avg | 7,610 | $1.1M | 100% |
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |